-+ 0.00%
-+ 0.00%
-+ 0.00%

SAREPTA THERAPEUTICS INC: FIRST-IN-HUMAN CLINICAL STUDY OF SRP-1005, KNOWN AS INSIGHTT, IS EXPECTED TO BEGIN IN Q2 OF 2026

Reuters·02/04/2026 13:30:02

Please log in to view news